Sixfold Bioscience
YC W18London, GB · Founded 2018 · 27 employees · 2 known investors
Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGene TherapyNanomedicineDrug Deliveryin /sixfoldbioscience/@sixfold_bio
Founders & leadership· Y Combinator alumni (W18)
Investors · 2
In the news
- £7.8m seed funding for MedTech Sixfold Biosciencebusinesscloud.co.uk · 2021
- Sixfold Bioscience completes $10.5 million seed financing - Drug Discovery World (DDW)ddw-online.com · 2021
- Sixfold Bioscience completes $10.5M USD (£7.8M GBP) seed financing — Sixfold.sixfold.bio · 2021
- Sixfold Bioscience - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021
- Cantos Ventures - 2026 Investor Profile, Portfolio, Team & Investment Trends - Tracxntracxn.com · 2021
- Sixfold Bioscience grows into new lab space at Imperial White City Incubator | Imperial News | Imperial College Londonimperial.ac.uk · 2019